fluticasone propionate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
FLIXOTIDE CFC-Free Fluticasone propionate 125 microgram/dose inhalation metered dose aerosol can AUST R: 63447Active ingredients:
fluticasone propionate
Dosage form:
Inhalation, pressurised
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
From
18 Sep 2024
to
31 Jan 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
Sponsor is working to expedite the next shipment. Alternative generic products are available.
|
FLUTICASONE CIPLA INHALER fluticasone propionate 125 microgram/actuation inhalation pressurised aerosol can metered dose AUST R: 270515Active ingredients:
fluticasone propionate
Dosage form:
Inhalation, pressurised
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
From
03 Nov 2023
to
15 Oct 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
FLIXONASE NASULE DROPS fluticasone propionate 400mcg unit dose ampoule strip pack AUST R: 71294Active ingredients:
fluticasone propionate
Dosage form:
Nasal Drops
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
Deletion from market:
15 Jul 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.
|
FLIXOTIDE NEBULES fluticasone propionate 0.5mg/2mL inhalation ampoule AUST R: 69004Active ingredients:
fluticasone propionate
Dosage form:
Inhalation, conventional
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
Deletion from market:
26 Feb 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.
|
FLIXOTIDE NEBULES fluticasone propionate 2.0mg/2mL inhalation ampoule AUST R: 69002Active ingredients:
fluticasone propionate
Dosage form:
Inhalation, conventional
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Phone:
1800033109
|
Deletion from market:
19 Nov 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Patients are advised to consult their healthcare professionals to discuss alternative treatment options.
|